The association between chronic inflammation and T2DM is now well established, and interleukin-1β (IL-1β), a pro-inflammatory cytokine, acts as a driving force in the pathogenesis of T2DM and related complications16–18. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.